World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
28625
World Ranking
15003
National Ranking
7584

Overview

B. Douglas Smith is affiliated with Johns Hopkins University in the United States and has a robust research presence in the field of medicine, with a particular focus on hematology. Their research covers a broad range of subfields, including genetics, molecular biology, public health, environmental and occupational health, and oncology.

The primary topics in their work emphasize leukemia research, especially acute myeloid leukemia and chronic myeloid leukemia treatments. Other research areas include chronic lymphocytic leukemia, acute lymphoblastic leukemia, myeloproliferative neoplasms relating to diagnosis and treatment, retinoids in leukemia and cellular processes, and eosinophilic disorders and syndromes.

B. Douglas Smith's publication record includes papers in several notable venues. The most frequent journals where their work appears include:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Leukemia Research
  • Leukemia
  • Clinical Cancer Research

Key recent papers authored or co-authored by B. Douglas Smith include:

  • Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology (2020), Journal of the National Comprehensive Cancer Network
  • Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia (2021), Blood Cancer Discovery
  • Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology (2024), Journal of the National Comprehensive Cancer Network
  • Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study (2020), Leukemia
  • Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults (2020), Blood Advances

Their frequent co-authors include Gabriel Ghiaur, Amy E. DeZern, Mark J. Levis, Ivana Gojo, and Jonathan Webster, reflecting ongoing collaborative work in hematology and leukemia research.

Best Publications

  • Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

    Donald B. Smith;Kevin S. Johnson

  • Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource

    Donald B. Smith;Jens Bukh;Carla Kuiken;A. Scott Muerhoff

  • Characterization of clonogenic multiple myeloma cells

    William H Matsui;Carol Ann Huff;Qiuju Wang;Matthew T Malehorn

  • ICTV Virus Taxonomy Profile: Flaviviridae.

    Peter Simmonds;Paul Becher;Jens Bukh;Ernest A. Gould

  • Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia

    B. Douglas Smith;Mark Levis;Mark Levis;Miloslav Beran;Miloslav Beran;Francis Giles;Francis Giles

  • Consensus proposals for classification of the family Hepeviridae

    Donald B. Smith;Peter Simmonds;Shahid Jameel

  • Nonmuscle Actin-Binding Proteins

    Stossel Tp;Chaponnier C;Ezzell Rm;Hartwig Jh

  • Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance

    William Matsui;Qiuju Wang;James P. Barber;Sarah Brennan

  • Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization

    B Robertson;G Myers;C Howard;T Brettin

  • A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo

    Mark Levis;Jeffrey Allebach;Kam-Fai Tse;Rui Zheng

  • Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms.

    Steven D. Gore;Stephen Baylin;Elizabeth Sugar;Hetty E. Carraway

  • High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

    Leo Luznik;Javier Bolaños-Meade;Marianna Zahurak;Allen R. Chen

  • Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

    Mark Levis;Farhad Ravandi;Eunice S. Wang;Maria R. Baer

  • Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

    Jorge E. Cortes;Florian H. Heidel;Andrzej Hellmann;Walter Fiedler

  • Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions

    P. Simmonds;D. B. Smith;F. McOmish;P. L. Yap

  • Proposed reference sequences for hepatitis E virus subtypes

    Donald B. Smith;Peter Simmonds;Jacques Izopet;Edmilson F. Oliveira-Filho

  • The origin of hepatitis C virus genotypes

    Donald B. Smith;Steve Pathirana;Fiona Davidson;Emer Lawlor

  • Risk-stratified outcomes of nonmyeloablative, HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

    Shannon R. McCurdy;Jennifer A. Kanakry;Margaret M. Showel;Hua Ling Tsai

  • Variation of the hepatitis C virus 5′ non-coding region: implications for secondary structure, virus detection and typing

    Donald B. Smith;Janet Mellor;Lisa M. Jarvis;Fiona Davidson

  • Immunoablative High-Dose Cyclophosphamide without Stem-Cell Rescue for Refractory, Severe Autoimmune Disease

    Robert A. Brodsky;Michelle Petri;B. Douglas Smith;Eric J. Seifter

Frequent Co-Authors

Judith E. Karp
Judith E. Karp Johns Hopkins University
Richard J. Jones
Richard J. Jones Johns Hopkins University
Mark J. Levis
Mark J. Levis Johns Hopkins University
Peter Simmonds
Peter Simmonds University of Oxford
Leo Luznik
Leo Luznik Johns Hopkins University
Michael A. McDevitt
Michael A. McDevitt Johns Hopkins University
Richard F. Ambinder
Richard F. Ambinder Johns Hopkins University
Ephraim J. Fuchs
Ephraim J. Fuchs Johns Hopkins University
Allan D. Hess
Allan D. Hess Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring a career in Medicine but seeking alternative or accelerated routes, there are several online degree options to consider. Nursing remains one of the most popular pathways, offering flexibility and accessibility for aspiring healthcare professionals.

For registered nurses looking to advance their credentials affordably, many schools offer the cheapest rn to bsn programs online. These programs enable working nurses to earn their Bachelor of Science in Nursing at a lower cost while continuing to work.

Prospective students without a nursing background but who want to enter the profession quickly can explore online direct entry msn programs. These allow those with a non-nursing bachelor’s degree to earn a Master of Science in Nursing in less time.

Applicants in search of less competitive admissions may prefer one of the easiest rn program options, which can increase the chances of starting a nursing career sooner.

Beyond nursing, allied health careers such as medical billing and coding are also in demand. You can find information about financial aid for medical billing and coding online classes, making this pathway even more accessible for those seeking a healthcare career without direct patient care.

Best Scientists Citing B. Douglas Smith

Trending Scientists

Recently Published Articles